Information on transaction in Company shares under Article 19 MAR

Current report no. 17/2025

Date of preparation: 28 February 2025

Subject: Information on transaction in Company shares under Article 19 MAR

Legal basis: Article 19(3) MAR - information on transactions carried out by management / closely related persons

Content of the report:

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) announces that it has received from Anna Pawluk, a person discharging managerial responsibilities, proxy of the Company, a notification of a transaction on the Company's shares (conclusion of a share subscription agreement), as referred to in Article 19(1) of the MAR Regulation.

The share subscription agreement was concluded within the framework of the incentive programme.

The content of the notification is attached to this report.